CCold sores (herpes labialis)
Adjunct
Cold sores (herpes labialis)
Adjunct
Many patients take L-lysine to reduce recurrent labial herpes episodes. A 2017 systematic review by Mailoo and Venkatakrishnan pooled about 12 studies, 7 of them RCTs: doses of 1–3 g/day reduced episode frequency or severity, but the meta-analysis was weak because of heterogeneous protocols and short follow-up. Herpes guidelines do not include lysine as standard. The standard for severe frequent recurrence remains antiviral aciclovir or valaciclovir. The review advises caution in patients with cardiovascular disease and gallstones (theoretical risk via reduced arginine). With rare mild episodes, many dermatologists accept a trial of lysine alongside discussing the plan with the doctor.
Sources
ICD-10: B00.1 · ICD-11: 1F00.01